Drug Description in Trials / DrugBank / KEGG DRUG /
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Copper | [1] Copper Copper | - | - | - | [4] 2 2, 169, 170, 171 |
2 | Copper Histidinate | [1] Copper Copper | - | - | - | [1] 169 169 |
3 | Copper Histidine | [2] Copper Copper,Histidine | [1] D00032
D00032
| - | - | [2] 169 169, 170 |
4 | Diethyldithiocarbamate | [1] Ditiocarb Ditiocarb | - | - | - | [1] 169 169 |
5 | Droxidopa | [1] Droxidopa Droxidopa | [1] D01277
D01277
| [9] ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 5 5, 6, 17, 169, 170 |
6 | Histidine | [1] Histidine Histidine | [1] D00032
D00032
| - | - | [3] 13 13, 169, 170 |
7 | Long Term Follow-Up | - | - | - | - | [1] 169 169 |